Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Total Voting Rights

29th Oct 2026 15:56

RNS Number : 0601B
Craneware plc
29 October 2026
 

 

Craneware plc

 

("Craneware" or the "Company" or the "Group")

 

Total Voting Rights

 

 

29 October 2026 - Following recent share plan awards transactions by employees, the Company has transferred or is transferring Ordinary Shares previously held in treasury to satisfy those vested share plan awards transactions.

 

As a result, the Company's issued share capital now consists of 35,542,169 Ordinary Shares, of which 1,157,528 remain held in treasury. Accordingly, the total number of Ordinary Shares in the Company with voting rights is 34,384,641. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

For further information, please contact:

 

Craneware plc +44 (0)131 550 3100

Keith Neilson, CEO

Craig Preston, CFO

 

Alma Strategic Communications (Financial PR) +44 (0)20 3405 0205

Caroline Forde, Louisa El-Ahwal [email protected]

Peel Hunt (NOMAD and Joint Broker) +44 (0)20 7418 8900

Neil Patel, Benjamin Cryer, Kate Bannatyne

Investec Bank PLC (Joint Broker) +44 (0)20 7597 5970

Patrick Robb, Virginia Bull, Arnav Kapoor

Berenberg (Joint Broker) +44 (0)20 3207 7800

Mark Whitmore, Tom Ballard, Patrick Dolaghan, Ryan Mahnke

About Craneware

For over 25 years, The Craneware Group (AIM:CRW.L) has been a leader in healthcare financial and operational transformation, delivering cutting-edge technologies that drive measurable impact. Our Trisus® cloud ecosystem unifies data, revenue intelligence, margin intelligence, and advanced analytics, enabling healthcare organizations to optimize performance, improve financial sustainability, and drive strategic growth. As a trusted Microsoft partner, we provide future-ready solutions-including the Best in KLAS Trisus Chargemaster - that simplify the complexities of healthcare finance and operations. What sets us apart is our unique combination of deep healthcare expertise and engineering excellence, positioning us as a strategic partner rather than just a technology provider. The Craneware Group empowers healthcare organizations to achieve sustainable financial success while delivering better outcomes for the communities they serve - today and in the future. Together, we are transforming the business of healthcare.

 

Learn more at www.thecranewaregroup.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRAKCBPPBDDQKB

Related Shares:

Craneware
FTSE 100 Latest
Value10,722.07
Change27.57